Your browser doesn't support javascript.
loading
Treating disease progression with osimertinib in EGFR-mutated non-small-cell lung cancer: novel targeted agents and combination strategies.
Di Noia, V; D'Aveni, A; D'Argento, E; Rossi, S; Ghirardelli, P; Bortolotti, L; Vavassori, V; Bria, E; Ceresoli, G L.
Affiliation
  • Di Noia V; Medical Oncology 1 Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. Electronic address: vincenzo.dinoia@ifo.gov.it.
  • D'Aveni A; Department of Medical Oncology 1, Cliniche Humanitas Gavazzeni, Bergamo, Italy.
  • D'Argento E; Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Rossi S; Department of Oncology and Hematology, Humanitas Clinical and Research Center, Rozzano, Italy.
  • Ghirardelli P; Department of Medical Oncology 1, Cliniche Humanitas Gavazzeni, Bergamo, Italy.
  • Bortolotti L; Department of Medical Oncology 1, Cliniche Humanitas Gavazzeni, Bergamo, Italy.
  • Vavassori V; Department of Medical Oncology 1, Cliniche Humanitas Gavazzeni, Bergamo, Italy.
  • Bria E; Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Istituto di Medicina Interna e Geriatria, Università; Cattolica del Sacro Cuore, Rome, Italy.
  • Ceresoli GL; Department of Medical Oncology 1, Cliniche Humanitas Gavazzeni, Bergamo, Italy.
ESMO Open ; 6(6): 100280, 2021 12.
Article in En | MEDLINE | ID: mdl-34634633
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: ESMO Open Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: ESMO Open Year: 2021 Type: Article